◆ NeutralARDX
ROSEN, TRUSTED TRIAL ATTORNEYS, Encourages Ardelyx, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action - ARDX
GlobeNewswire Inc.·
Rosen Law Firm is notifying investors who purchased Ardelyx common stock between January 13, 2025 and August 6, 2026 of an important November 16, 2026 lead plaintiff deadline in a securities class action. The lawsuit alleges that Ardelyx provided false and misleading statements regarding commercial performance and growth prospects for its products XPHOZAH and IBSRELA, while concealing material facts about payer-related access barriers, prior authorization requirements, and step edit requirements that hindered patient access.
Read Full Article at GlobeNewswire Inc. →